Latest Headlines

Latest Headlines

Botox rivals could fuel big DTC fight

Watch out, Botox. A couple of competitors could soon be breathing down your wrinkle-free neck. France's Ipsen has won U.K. approval to sell its muscle relaxant Azzalure for use against brow

Ipsen clears FDA hurdle, gains $25M for Reloxin BLA

France's Ipsen gained $25 million from Medicis Pharmaceutical on the news that the FDA has accepted the BLA filing for Reloxin, a next-gen competitor to Allergan's Botox. And analysts say the therapy